Franklin Genomic Advancements ETF HELX
Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed
- Expense ratio
- 0.50%
- Net assets
- $27.9M
- Holdings
- 63
- 12-month distribution yield
- 0.34%
- Asset class
- Equity
Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund listed on Cboe BZX in the United States, issued by Franklin Templeton. Its category is Equity · US (equity). Its last price was US$41.66 on 20 Oct 2026. Its expense ratio is 0.5% a year, from its prospectus dated 1 Aug 2025. It reported net assets of US$27.94 million as of 30 Jun 2026. Its latest holdings report lists 63 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.14 a unit, a 12-month distribution yield of 0.34%.
Fees
- Total annual operating expenses (gross)
- 0.50%
- Net, after fee waivers or reimbursements
- No waiver stated
- Management fee
- 0.50%
- Prospectus date
- 1 Aug 2025
- Filed with the SEC
- 28 Jul 2025
Size and reporting
- Net assets
- $27,936,547
- Total assets
- $27,946,260
- Holdings as of
- 30 Jun 2026
- Report made public
- 27 Aug 2026 (58 days after the month end)
Top holdings
Largest 25 of 63 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.
| # | Holding | Identifier | Weight | Value (USD) | Type | Country | Currency |
|---|---|---|---|---|---|---|---|
| 1 | GUARDANT HEALTH INC GUARDANT HEALTH INC COM | US40131M1099 | 9.09% | $2.5M | Equity (common) | United States | USD |
| 2 | NATERA INC NATERA INC COM | US6323071042 | 7.46% | $2.1M | Equity (common) | United States | USD |
| 3 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 6.33% | $1.8M | Equity (common) | United States | USD |
| 4 | LIGAND PHARMACEUTICALS INC LIGAND PHARMACEUTICALS INC COM NEW | US53220K5048 | 4.62% | $1.3M | Equity (common) | United States | USD |
| 5 | ADAPTIVE BIOTECHNOLOGIES CORP ADAPTIVE BIOTECHNOLOGIES CORP COM | US00650F1093 | 3.99% | $1.1M | Equity (common) | United States | USD |
| 6 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 3.51% | $980K | Equity (common) | United States | USD |
| 7 | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM | US10806X1028 | 3.50% | $978K | Equity (common) | United States | USD |
| 8 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 2.95% | $825K | Equity (common) | United States | USD |
| 9 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 2.85% | $796K | Equity (common) | United States | USD |
| 10 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 2.75% | $767K | Equity (common) | United States | USD |
| 11 | ASTRAZENECA PLC ASTRAZENECA PLC ORD USD0.25 | GB0009895292 | 2.70% | $754K | Equity (common) | United Kingdom | USD |
| 12 | TRAVERE THERAPEUTICS INC TRAVERE THERAPEUTICS INC COM | US89422G1076 | 2.59% | $724K | Equity (common) | United States | USD |
| 13 | INSMED INC INSMED INC COM PAR $.01 | US4576693075 | 2.44% | $681K | Equity (common) | United States | USD |
| 14 | SAMSUNG BIOLOGICS CO LTD SAMSUNG BIOLOGICS CO LTD KRW2500 | KR7207940008 | 2.26% | $630K | Equity (common) | South Korea | KRW |
| 15 | CORTEVA INC CORTEVA INC COM | US22052L1044 | 2.25% | $630K | Equity (common) | United States | USD |
| 16 | MEDPACE HOLDINGS INC MEDPACE HOLDINGS INC COM | US58506Q1094 | 2.15% | $600K | Equity (common) | United States | USD |
| 17 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 1.96% | $547K | Equity (common) | United States | USD |
| 18 | TEMPUS AI INC TEMPUS AI INC CL A | US88023B1035 | 1.95% | $544K | Equity (common) | United States | USD |
| 19 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 1.91% | $534K | Equity (common) | United States | USD |
| 20 | NEUROCRINE BIOSCIENCES INC NEUROCRINE BIOSCIENCES INC COM | US64125C1099 | 1.84% | $515K | Equity (common) | United States | USD |
| 21 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 1.80% | $502K | Equity (common) | United States | USD |
| 22 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 1.64% | $459K | Equity (common) | United States | USD |
| 23 | ARGENX SE ARGENX SE EUR0.10 | NL0010832176 | 1.64% | $458K | Equity (common) | Netherlands | EUR |
| 24 | PTC THERAPEUTICS INC PTC THERAPEUTICS INC COM | US69366J2006 | 1.46% | $409K | Equity (common) | United States | USD |
| 25 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 1.38% | $387K | Equity (common) | Germany | USD |
Breakdowns
Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.
Asset type
| Type | Weight | Bar |
|---|---|---|
| Equity (common) | 97.88% | |
| Equity (preferred) | 0.85% |
Country
| Country | Weight | Bar |
|---|---|---|
| United States | 86.61% | |
| United Kingdom | 3.04% | |
| South Korea | 2.63% | |
| Germany | 2.23% | |
| Netherlands | 2.12% | |
| Switzerland | 1.21% | |
| Ireland | 0.78% | |
| Singapore | 0.10% |
Currency exposure
| Currency | Weight | Bar |
|---|---|---|
| US dollar (USD) | 93.61% | |
| South Korean won (KRW) | 2.63% | |
| Euro (EUR) | 2.49% |
Sector
| Sector | Weight | Bar |
|---|---|---|
| Health Care | 60.93% | |
| Technology | 3.62% | |
| Consumer Staples | 2.25% | |
| Industrials | 2.17% | |
| Health Technology | 0.77% |
Source: SEC Form N-PORT (opens in a new tab) Holdings as of
Distributions
- Paid in the last 12 months
- $0.1430
- 12-month yield
- 0.34%
- Frequency
- Irregular
- Latest ex-date
- 30 Dec 2025
12-month yield = distributions per unit with an ex-date in the last 12 months ($0.1430) ÷ latest price ($41.66) × 100 = 0.34%. It looks back, so it is not a forecast; special distributions in the window are included.
Why a distribution yield is not the fund's return: yield vs total return
Distribution history table (3 payments)
| Ex-date | Amount per unit |
|---|---|
| 30 Dec 2025 | $0.1430 |
| 30 Dec 2021 | $0.0040 |
| 13 Dec 2021 | $0.1140 |
Filings and sources
- Form N-PORT report for June 2026 (opens in a new tab)
- Prospectus filing with the fee table (opens in a new tab)
- All SEC filings for this fund series (S000067393) (opens in a new tab)
- Nasdaq Trader symbol directory (opens in a new tab)
- Yahoo Finance quote and distributions (opens in a new tab)
- How the ETF figures are collected
Compare with
Largest funds in the same category:
- HELX and VTI Vanguard Morningstar Total Stock Market ETF
- HELX and VOO Vanguard S&P 500 ETF
- HELX and IVV iShares Core S&P 500 ETF
- HELX and QQQ Invesco QQQ Trust, Series 1